These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18485547)

  • 61. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
    Blair PJ; Kochel TJ; Raviprakash K; Guevara C; Salazar M; Wu SJ; Olson JG; Porter KR
    Vaccine; 2006 Feb; 24(9):1427-32. PubMed ID: 16214271
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
    J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S; Wang S; Britt WJ; Lu S
    Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y; Cyr SL; Burt DS; Anderson R
    J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
    Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of a needle-free delivery platform for prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus 2 glycoprotein D.
    Meseda CA; Stout RR; Weir JP
    Viral Immunol; 2006; 19(2):250-9. PubMed ID: 16817767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.
    Phelps A; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2005 May; 23(27):3500-7. PubMed ID: 15855008
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge.
    Vliegen I; Yang G; Hruby D; Jordan R; Neyts J
    Antiviral Res; 2012 Jan; 93(1):160-6. PubMed ID: 22138484
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
    Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
    Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH; BANG HS; CHO HW; CHUNG YH
    Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene.
    Li B; Xiao S; Wang Y; Xu S; Jiang Y; Chen H; Fang L
    Vaccine; 2009 Mar; 27(13):1957-63. PubMed ID: 19368777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
    Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
    J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.